Assignee
NOMOCAN PHARMACEUTICALS LLC
US·1 granted patent·3 pending applications·2 citations·filing 2018–2022
Top patents by PatentIndex Score
4 records- 0173US11407840B2Antibodies to M(H)DM2/4 and their use in diagnosing and treating cancerNOMOCAN PHARMACEUTICALS LLC·Filed 2021·Granted Aug 9, 2022·2 cites·20 claims
- 0255US2023295341A1Antibodies to m(h)dm2/4 and their use in diagnosing and treating cancerNOMOCAN PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 0344US2021032364A1Antibodies to m(h)dm2/4 and their use in diagnosing and treating cancerNOMOCAN PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 0426US2022098328A1Antibodies to m(h)dm2/4 and their use in diagnosing and treating cancerNOMOCAN PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NOMOCAN PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →